Bibliography for BS3530: Applications of Genetic Engineering in Health and Disease BETA

‘A Third-Generation Lentivirus Vector With a Conditional Packaging System’ (1998) Journal of Virology, 72(11). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC110254/.

Adams, D. (2018) ‘Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis’, New England Journal of Medicine, 379(1), pp. 11–21. Available at: https://doi.org/10.1056/NEJMoa1716153.

Addgene Plasmids 101: The Promoter Region – Let’s Go! (no date). Available at: https://blog.addgene.org/plasmids-101-the-promoter-region.

Adley, K.E., Keim, M. and Williams, R.S.B. (2006) ‘Pharmacogenetics: Defining the Genetic Basis of Drug Action and Inositol Trisphosphateanalysis’, in Dictyostelium Discoideum Protocols. Totowa, N.J.: Humana Press, pp. 507–516.

Alberts, B. (2015) Molecular Biology of the Cell. Sixth edition. New York, NY: Garland Science.

Allen, A.G. (2018) ‘Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection’, Frontiers in Microbiology, 9. Available at: https://doi.org/10.3389/fmicb.2018.02940.

Amoasii, L. (2018) ‘Gene Editing Restores Dystrophin Expression in a Canine Model of Duchenne Muscular Dystrophy’, Science, 362(6410), pp. 86–91. Available at: https://doi.org/10.1126/science.aau1549.

Barrangou, R. (2015) ‘Diversity of CRISPR-Cas Immune Systems and Molecular Machines’, Genome Biology, 16(1). Available at: https://doi.org/10.1186/s13059-015-0816-9.

Biology and Ecology of Baculoviruses (Baculoviridae) (no date). Available at: http://www.trevorwilliams.info/Ecology_baculoviruses.htm.

Birling, M.-C., Herault, Y. and Pavlovic, G. (2017) ‘Modeling Human Disease in Rodents by CRISPR/Cas9 Genome Editing’, Mammalian Genome, 28(7–8), pp. 291–301. Available at: https://doi.org/10.1007/s00335-017-9703-x.

Boeckeler, K. and Williams, R.S. (1999) ‘Dictyostelium as a Biomedical Model’, in Encyclopedia of Life Sciences. Wiley Interscience. Available at: https://doi.org/10.1002/9780470015902.a0006038.

Breen, G. and Harwood, A.J. (2004) ‘Two Peptidase Activities Decrease in Treated Bipolar Disorder Not Schizophrenic Patients’, Bipolar Disorders, 6(2), pp. 156–161. Available at: https://doi.org/10.1111/j.1399-5618.2004.00100.x.

Brown, B.D. et al. (2006) ‘803. Endogenous microRNA Regulation Suppresses Transgene Expression in Hematopoietic Lineages and Enables Stable Gene Transfer’, Molecular Therapy, 13. Available at: https://doi.org/10.1016/j.ymthe.2006.08.1224.

Burke, C.R. and Lupták, A. (1999) ‘Catalytic RNA’, in Encyclopedia of Life Sciences. Wiley Interscience. Available at: https://doi.org/10.1002/9780470015902.a0000870.pub2.

Burnett, J.C. and Rossi, J.J. (2012) ‘RNA-Based Therapeutics: Current Progress and Future Prospects’, Chemistry & Biology, 19(1), pp. 60–71. Available at: https://doi.org/10.1016/j.chembiol.2011.12.008.

CAR T Cells: Engineering Immune Cells to Treat Cancer - National Cancer Institute (no date). Available at: https://www.cancer.gov/about-cancer/treatment/research/car-t-cells.

Cartier, N. (2009) ‘Hematopoietic Stem Cell Gene Therapy With a Lentiviral Vector in X-Linked Adrenoleukodystrophy’, Science, 326(5954). Available at: https://www.jstor.org/stable/40328789?seq=1#metadata_info_tab_contents.

Chang, P. and Orabi, B. (2012a) ‘The Antiepileptic Drug Valproic Acid and Other Medium-Chain Fatty Acids Acutely Reduce Phosphoinositide Levels Independently of Inositol in Dictyostelium’, Disease Models & Mechanisms, 5(1). Available at: https://doi.org/10.1242/dmm.008029.

Chang, P. and Orabi, B. (2012b) ‘The Antiepileptic Drug Valproic Acid and Other Medium-Chain Fatty Acids Acutely Reduce Phosphoinositide Levels Independently of Inositol in Dictyostelium’, Disease Models & Mechanisms, 5(1). Available at: https://doi.org/10.1242/dmm.008029.

Colella, P. and Sellier, P. (2019) ‘AAV Gene Transfer With Tandem Promoter Design Prevents Anti-Transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice’, Molecular Therapy - Methods & Clinical Development, 12, pp. 85–101. Available at: https://doi.org/10.1016/j.omtm.2018.11.002.

Cuende, N. (2018) ‘Cell, Tissue and Gene Products With Marketing Authorization in 2018 Worldwide’, Cytotherapy, 20(11), pp. 1401–1413. Available at: https://doi.org/10.1016/j.jcyt.2018.09.010.

Cunliffe, V.T. and Baines, R.A. (2015) ‘Epilepsy Research Methods Update: Understanding the Causes of Epileptic Seizures and Identifying New Treatments Using Non-Mammalian Model Organisms’, Seizure, 24, pp. 44–51. Available at: https://doi.org/10.1016/j.seizure.2014.09.018.

Delhove, J.M.K.M. and Qasim, W. (2017) ‘Genome-Edited T Cell Therapies’, Current Stem Cell Reports, 3(2), pp. 124–136. Available at: https://doi.org/10.1007/s40778-017-0077-5.

Eichinger, L. and Pachebat, J.A. (2005) ‘The Genome of the Social Amoeba Dictyostelium Discoideum’, Nature, 435(7038), pp. 43–57. Available at: https://doi.org/10.1038/nature03481.

Eickholt, B.J., Williams, R.S.B. and Harwood, A.J. (2004) ‘Mood Stabilizers and the Cell Biology of Neuronal Growth Cones’, Clinical Neuroscience Research, 4(3–4), pp. 189–199. Available at: https://doi.org/10.1016/j.cnr.2004.09.011.

Ennis, H.L. and Dao, D.N. (2000) ‘Dictyostelium Amoebae Lacking an F-Box Protein Form Spores Rather than Stalk in Chimeras with Wild Type’, Proceedings of the National Academy of Sciences of the United States of America, 97(7), pp. 3292–3297. Available at: http://www.jstor.org/stable/121885?seq=1#page_scan_tab_contents.

‘Expression of Recombinant Proteins in Yeast’ (no date). Available at: http://www.biopharminternational.com/expression-recombinant-proteins-yeast.

Fey, P. et al. (2013) ‘One Stop Shop for Everything Dictyostelium: dictyBase and the Dicty Stock Center in 2012’, in Dictyostelium Discoideum Protocols. Second edition. New York: Humana Press.

Finkel, R.S. (no date) ‘Nusinersen Versus Sham Control in Infantile-Onset Spinal Muscular Atrophy’, New England Journal of Medicine, 377(18), pp. 1723–1732. Available at: https://doi.org/10.1056/NEJMoa1702752EnglishyesA1000414239100005MEDICINE, GENERAL & INTERNAL79.258 (2017)1/154 (2017)1 (2017)I have transferred the copyright for this publication to the publisher8542659http://hdl.handle.net/1854/LU-85426592017-12-20 09:16:452018-11-13 14:56:36.

Fischer, M. et al. (2004) ‘A Brilliant Monomeric Red Fluorescent Protein to Visualize Cytoskeleton Dynamics in Dictyostelium’, FEBS Letters, 577(1–2), pp. 227–232. Available at: https://doi.org/10.1016/j.febslet.2004.09.084.

Fischer, M. et al. (2006) ‘Visualizing Cytoskeleton Dynamics in Mammalian Cells Using a Humanized Variant of Monomeric Red Fluorescent Protein’, FEBS Letters, 580(10), pp. 2495–2502. Available at: https://doi.org/10.1016/j.febslet.2006.03.082.

Foster, K.R. and Shaulsky, G. (2004) ‘Pleiotropy as a Mechanism to Stabilize Cooperation’, Nature, 431(7009), pp. 693–696. Available at: https://doi.org/10.1038/nature02894.

Fu, Y. (2014) ‘Improving CRISPR-Cas Nuclease Specificity Using Truncated Guide RNAs’, Nature Biotechnology, 32(3), pp. 279–284. Available at: https://doi.org/10.1038/nbt.2808.

Gaj, T. (2016) ‘Genome-Editing Technologies: Principles and Applications’, Cold Spring Harbor Perspectives in Biology, 8(12). Available at: https://doi.org/10.1101/cshperspect.a023754.

Gardner, E.J. (1991) Principles of Genetics. 8th ed. New York: Wiley.

Grzech, M. (2010) ‘Specific Transgene Expression in Mouse Pancreatic β-Cells Under the Control of the Porcine Insulin Promoter’, Molecular and Cellular Endocrinology, 315(1–2), pp. 219–224. Available at: https://doi.org/10.1016/j.mce.2009.08.001.

Grzegorski, S.J. and Chiari, E.F. (2014) ‘Natural Variability of Kozak Sequences Correlates with Function in a Zebrafish Model’, PLoS ONE, 9(9). Available at: https://doi.org/10.1371/journal.pone.0108475.

Guha, T.K. (2017) ‘Programmable Genome Editing Tools and Their Regulation for Efficient Genome Engineering’, Computational and Structural Biotechnology Journal, 15, pp. 146–160. Available at: https://doi.org/10.1016/j.csbj.2016.12.006.

‘Guide to Baculovirus Expression Vector Systems (BEVS) and Insect Cell Culture Techniques’ (no date). Available at: http://tools.thermofisher.com/content/sfs/manuals/bevtest.pdf.

Hartmann, J. et al. (2017) ‘Clinical Development of CAR T Cells—challenges and Opportunities in Translating Innovative Treatment Concepts’, EMBO Molecular Medicine, 9(9), pp. 1183–1197. Available at: https://doi.org/10.15252/emmm.201607485.

Ho, B. (2018) ‘In Vivo Genome Editing as a Therapeutic Approach’, International Journal of Molecular Sciences, 19(9). Available at: https://doi.org/10.3390/ijms19092721.

Howard, H.C. (2018) ‘One Small Edit for Humans, One Giant Edit for Humankind? Points and Questions to Consider for a Responsible Way Forward for Gene Editing in Humans’, European Journal of Human Genetics, 26(1), pp. 1–11. Available at: https://doi.org/10.1038/s41431-017-0024-z.

Janetopoulos, C. and Firtel, R.A. (2008) ‘Directional Sensing During Chemotaxis’, FEBS Letters, 582(14), pp. 2075–2085. Available at: https://doi.org/10.1016/j.febslet.2008.04.035.

Jasin, M. and Haber, J.E. (2016) ‘The Democratization of Gene Editing: Insights From Site-Specific Cleavage and Double-Strand Break Repair’, DNA Repair, 44, pp. 6–16. Available at: https://doi.org/10.1016/j.dnarep.2016.05.001.

Jonathan Ryves, W. et al. (2005) ‘GSK-3 Activity in Neocortical Cells Is Inhibited by Lithium but Not Carbamazepine or Valproic Acid’, Bipolar Disorders, 7(3), pp. 260–265. Available at: https://doi.org/10.1111/j.1399-5618.2005.00194.x.

Keim, M., Williams, R.S.B. and Harwood, A.J. (2004) ‘An Inverse PCR Technique to Rapidly Isolate the Flanking DNA of Dictyostelium Insertion Mutants’, Molecular Biotechnology, 26(3), pp. 221–224. Available at: https://doi.org/10.1385/MB:26:3:221.

Kinch, M.S. (2015) ‘An Overview of FDA-Approved Biologics Medicines’, Drug Discovery Today, 20(4), pp. 393–398. Available at: https://doi.org/10.1016/j.drudis.2014.09.003.

Kotterman, M.A. and Schaffer, D.V. (2014) ‘Engineering Adeno-Associated Viruses for Clinical Gene Therapy’, Nature Reviews Genetics, 15(7), pp. 445–451. Available at: https://doi.org/10.1038/nrg3742.

Kwarteng, A., Ahuno, S.T. and Kwakye-Nuako, G. (2017) ‘The Therapeutic Landscape of HIV-1 via Genome Editing’, AIDS Research and Therapy, 14(1). Available at: https://doi.org/10.1186/s12981-017-0157-8.

KYMRIAH® (tisagenlecleucel) | Health Care Professionals (no date). Available at: https://www.hcp.novartis.com/products/kymriah/acute-lymphoblastic-leukemia-children.

Lee, J.G., Sung, Y.H. and Baek, I.-J. (2018) ‘Generation of Genetically-Engineered Animals Using Engineered Endonucleases’, Archives of Pharmacal Research, 41(9), pp. 885–897. Available at: https://doi.org/10.1007/s12272-018-1037-z.

Levine, B.L. (2006) ‘Gene Transfer in Humans Using a Conditionally Replicating Lentiviral Vector’, Proceedings of the National Academy of Sciences, 103(46), pp. 17372–17377. Available at: https://doi.org/10.1073/pnas.0608138103.

Lewin, B. (2008) Genes IX. 9th ed. Sudbury, Mass: Jones and Bartlett.

Lim, K., Yoon, C. and Yokota, T. (2018) ‘Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy’, Journal of Personalized Medicine, 8(4). Available at: https://doi.org/10.3390/jpm8040038.

Lino, C.A. (2018) ‘Delivering CRISPR: A Review of the Challenges and Approaches’, Drug Delivery, 25(1), pp. 1234–1257. Available at: https://doi.org/10.1080/10717544.2018.1474964.

Lodish, H.F. (2016) Molecular Cell Biology. Eighth edition. New York: W.H. Freeman Macmillan Learning.

Loomis, W.F. and Shaulsky, G. (2011) ‘Developmental Changes in Transcriptional Profiles’, Development, Growth & Differentiation, 53(4), pp. 567–575. Available at: https://doi.org/10.1111/j.1440-169X.2010.01241.x.

Ludtmann, M.H.R. and Otto, G.P. (2014) ‘An Ancestral Non-Proteolytic Role for Presenilin Proteins in Multicellular Development of the Social Amoeba Dictyostelium Discoideum’, Journal of Cell Science, 127(7), pp. 1576–1584. Available at: https://doi.org/10.1242/jcs.140939.

Mahajan, M.C., Karmakar, S. and Weissman, S.M. (2007) ‘Control of Beta Globin Genes’, Journal of Cellular Biochemistry, 102(4), pp. 801–810. Available at: https://doi.org/10.1002/jcb.21507.

Manahan, C.L. et al. (2004) ‘Chemoattractant Signaling In’, Annual Review of Cell and Developmental Biology, 20(1), pp. 223–253. Available at: https://doi.org/10.1146/annurev.cellbio.20.011303.132633.

Maude, S.L. (2014) ‘Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia’, New England Journal of Medicine, 371(16), pp. 1507–1517. Available at: https://doi.org/10.1056/NEJMoa1407222.

McCarty, D.M. (2008) ‘Self-Complementary AAV Vectors; Advances and Applications’, Molecular Therapy, 16(10), pp. 1648–1656. Available at: https://doi.org/10.1038/mt.2008.171.

McMains, V.C. et al. (2010) ‘Dictyostelium Possesses Highly Diverged Presenilin/Y-Secretase That Regulates Growth and Cell-Fate Specification and Can Accurately Process Human APP: A System for Functional Studies of the Presenilin/Y-Secretase Complex’, Disease Models & Mechanisms, 3(9–10), pp. 581–594. Available at: https://doi.org/10.1242/dmm.004457.

Mendell, J.R. (2017) ‘Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy’, New England Journal of Medicine, 377(18), pp. 1713–1722. Available at: https://doi.org/10.1056/NEJMoa1706198.

Miccio, A. (2008) ‘In Vivo Selection of Genetically Modified Erythroblastic Progenitors Leads to Long-Term Correction of  -Thalassemia’, Proceedings of the National Academy of Sciences, 105(30), pp. 10547–10552. Available at: https://doi.org/10.1073/pnas.0711666105.

Milone, M.C. (2009) ‘Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy in Vivo’, Molecular Therapy, 17(8), pp. 1453–1464. Available at: https://doi.org/10.1038/mt.2009.83.

Milone, M.C. and O’Doherty, U. (2018) ‘Clinical Use of Lentiviral Vectors’, Leukemia, 32(7), pp. 1529–1541. Available at: https://doi.org/10.1038/s41375-018-0106-0.

Mohanty, S. (2001) ‘Regulated Protein Degradation Controls PKA Function and Cell-Type Differentiation in Dictyostelium’, Genes & Development, 15(11), pp. 1435–1448. Available at: https://doi.org/10.1101/gad.871101.

Morton, C.L. and Potter, P.M. (2000) ‘Comparison of Escherichia Coli, Saccharomyces Cerevisiae, Pichia Pastoris, Spodoptera Frugiperda, and COS7 Cells for Recombinant Gene Expression: Application to a Rabbit Liver Carboxylesterase’, Molecular Biotechnology, 16(3), pp. 193–202. Available at: https://doi.org/10.1385/MB:16:3:193.

Müller-Taubenberger, A. (2011a) ‘Great Lessons Told by Little Cells: The Model Organism Dictyostelium Discoideum’, Cell News. Available at: https://zellbiologie.de/cellnews/wp-content/uploads/2015/03/CellNews_04_11.pdf.

Müller-Taubenberger, A. (2011b) ‘Great Lessons Told by Little Cells: The Model Organism Dictyostelium Discoideum’ in Cell News’, Cell News. Available at: https://zellbiologie.de/cellnews/wp-content/uploads/2015/03/CellNews_04_11.pdf.

Mulvihill, J.J. (2017) ‘Ethical Issues of CRISPR Technology and Gene Editing Through the Lens of Solidarity’, British Medical Bulletin, 122(1), pp. 17–29. Available at: https://doi.org/10.1093/bmb/ldx002.

Mussolino, C. (2017) ‘Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System’, Human Gene Therapy, 28(11), pp. 1105–1115. Available at: https://doi.org/10.1089/hum.2017.149.

Nakade, S., Yamamoto, T. and Sakuma, T. (2017) ‘Cas9, Cpf1 and C2c1/2/3―What’s Next?’, Bioengineered, 8(3), pp. 265–273. Available at: https://doi.org/10.1080/21655979.2017.1282018.

Naldini, L. (2015) ‘Gene Therapy Returns to Centre Stage’, Nature, 526(7573), pp. 351–360. Available at: https://doi.org/10.1038/nature15818.

Naldini, L., Trono, D. and Verma, I.M. (2016) ‘Lentiviral Vectors, Two Decades Later’, Science, 353(6304), pp. 1101–1102. Available at: https://doi.org/10.1126/science.aah6192.

Nie, J. and Hashino, E. (2017) ‘Organoid Technologies Meet Genome Engineering’, EMBO reports, 18(3), pp. 367–376. Available at: https://doi.org/10.15252/embr.201643732.

Nielsen, J. (2013) ‘Production of Biopharmaceutical Proteins by Yeast’, Bioengineered, 4(4), pp. 207–211. Available at: https://doi.org/10.4161/bioe.22856.

Olson, S. (2016) ‘International Summit on Human Gene Editing: A Global Discussion’. National Academies Press (US). Available at: https://www.ncbi.nlm.nih.gov/books/NBK343651/.

‘Onpattro Patient Brochure’ (no date). Available at: https://www.onpattro.com/wp-content/uploads/2018/08/ONPATTRO-Patient-Brochure.pdf.

Otto, G.P., Sharma, D. and Williams, R.S.B. (2016) ‘Non-Catalytic Roles of Presenilin Throughout Evolution’, Journal of Alzheimer’s Disease, 52(4), pp. 1177–1187. Available at: https://doi.org/10.3233/JAD-150940.

Otto, G.P. and Williams, R.S.B. (2014) ‘Social Amoeba and Dementia: Dictyostelium as an Animal Replacement Model for Research Into Alzheimer’s Disease’, Biochemist [Preprint]. Available at: https://www.researchgate.net/publication/281691570_Social_amoeba_and_dementia_Dictyostelium_as_an_animal_replacement_model_for_research_into_Alzheimer’s_disease.

Pakes, N.K. (2012) ‘The Rac GEF ZizB Regulates Development, Cell Motility and Cytokinesis in Dictyostelium’, Development, 139(15), pp. e1–e1. Available at: https://doi.org/10.1242/dev.086082.

Pakes, N.K., Veltman, D.M. and Williams, R.S.B. (2013) ‘Zizimin and Dock Guanine Nucleotide Exchange Factors in Cell Function and Disease’, Small GTPases, 4(1), pp. 22–27. Available at: https://doi.org/10.4161/sgtp.22087.

Palfi, S. (2014) ‘Long-Term Safety and Tolerability of ProSavin, a Lentiviral Vector-Based Gene Therapy for Parkinson’s Disease: A Dose Escalation, Open-Label, Phase 1/2 Trial’, The Lancet, 383(9923), pp. 1138–1146. Available at: https://doi.org/10.1016/S0140-6736(13)61939-X.

Palfi, S. (2018) ‘Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson’s Disease’, Human Gene Therapy Clinical Development, 29(3), pp. 148–155. Available at: https://doi.org/10.1089/humc.2018.081.

Pannunzio, N.R. (2018) ‘Nonhomologous DNA End-Joining for Repair of DNA Double-Strand Breaks’, Journal of Biological Chemistry, 293(27), pp. 10512–10523. Available at: https://doi.org/10.1074/jbc.TM117.000374.

Pei, D. (2017) ‘Human Embryo Editing: Opportunities and Importance of Transnational Cooperation’, Cell Stem Cell, 21(4), pp. 423–426. Available at: https://doi.org/10.1016/j.stem.2017.09.010.

‘PichiaPink^TM Expression System’ (no date). Available at: http://tools.thermofisher.com/content/sfs/manuals/pichiapink_expression_system_man.pdf.

Qin, J.Y. (2010) ‘Systematic Comparison of Constitutive Promoters and the Doxycycline-Inducible Promoter’, PLoS ONE, 5(5). Available at: https://doi.org/10.1371/journal.pone.0010611.

Rothfels, H., Paschen, A. and Schadendorf, D. (2003) ‘Evaluation of Combined Gene Regulatory Elements for Transcriptional Targeting of Suicide Gene Expression to Malignant Melanoma’, Experimental Dermatology, 12(6), pp. 799–810. Available at: https://doi.org/10.1111/j.0906-6705.2003.00093.x.

Ryan, D.E. (2018) ‘Improving CRISPR–Cas Specificity With Chemical Modifications in Single-Guide RNAs’, Nucleic Acids Research, 46(2), pp. 792–803. Available at: https://doi.org/10.1093/nar/gkx1199.

Saha, S.K. (2019) ‘Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech’, Molecular Therapy - Nucleic Acids, 14, pp. 212–238. Available at: https://doi.org/10.1016/j.omtn.2018.11.016.

Santorelli, L.A. and Thompson, C.R.L. (2008) ‘Facultative Cheater Mutants Reveal the Genetic Complexity of Cooperation in Social Amoebae’, Nature, 451(7182), pp. 1107–1110. Available at: https://doi.org/10.1038/nature06558.

Scholefield, J. and Weinberg, M.S. (2016) ‘The Application of CRISPR/Cas9 Technologies and Therapies in Stem Cells’, Current Stem Cell Reports, 2(2), pp. 95–103. Available at: https://doi.org/10.1007/s40778-016-0043-7.

‘Self-Inactivating Lentivirus Vector for Safe and  Efficient In Vivo Gene Delivery’ (1998) Journal of Virology, 72(12). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC110499/.

Shaulsky, G. and Kessin, R.H. (2007) ‘The Cold War of the Social Amoebae’, Current Biology, 17(16), pp. R684–R692. Available at: https://doi.org/10.1016/j.cub.2007.06.024.

Shen, J. and Kelleher, III, R.J. (2007) ‘The Presenilin Hypothesis of Alzheimer’s Disease: Evidence for a Loss-of-Function Pathogenic Mechanism’, Proceedings of the National Academy of Sciences of the United States of America, 104(2), pp. 403–409. Available at: http://www.jstor.org/stable/25426114?seq=1#page_scan_tab_contents.

Shim, G. (2017) ‘Therapeutic Gene Editing: Delivery and Regulatory Perspectives’, Acta Pharmacologica Sinica, 38(6), pp. 738–753. Available at: https://doi.org/10.1038/aps.2017.2.

Stinski, M.F. and Isomura, H. (2008) ‘Role of the Cytomegalovirus Major Immediate Early Enhancer in Acute Infection and Reactivation From Latency’, Medical Microbiology and Immunology, 197(2), pp. 223–231. Available at: https://doi.org/10.1007/s00430-007-0069-7.

Strachan, T. and Read, A. (2011a) ‘Gene Approaches to Treating Disease’, in Human Molecular Genetics. 4th ed. New York: Garland Science.

Strachan, T. and Read, A. (2011b) ‘Genetic Manipulation of Animals for Modeling Disease and Investigating Gene Function’, in Human Molecular Genetics. 4th ed. New York: Garland Science.

Strachan, T. and Read, A. (2011c) ‘Organisation of the Human Genome’, in Human Molecular Genetics. 4th ed. New York: Garland Science.

Strachan, T. and Read, A. (2011d) ‘Studying Gene Function in the Post-Genome Era’, in Human Molecular Genetics. 4th ed. New York: Garland Science.

Strachan, T. and Read, A.P. (2011a) ‘Human Gene Expression’, in Human Molecular Genetics. 4th ed. New York: Garland Science.

Strachan, T. and Read, A.P. (2011b) ‘Nucleic Acid Structure and Gene Expression’, in Human Molecular Genetics. 4th ed. New York: Garland Science.

Strachan, T. and Read, A.P. (2011c) ‘Organisation of the Human Genome’, in Human Molecular Genetics. 4th ed. New York: Garland Science.

Strachan, T., Read, A.P. and Strachan, Tom (2011) Human Molecular Genetics. 4th ed. New York: Garland Science.

Strassmann, J.E. and Queller, D.C. (2011) ‘Evolution of Cooperation and Control of Cheating in a Social Microbe’, Proceedings of the National Academy of Sciences, 108(Supplement_2), pp. 10855–10862. Available at: https://doi.org/10.1073/pnas.1102451108.

Sun, Y. and Ding, Q. (2017) ‘Genome Engineering of Stem Cell Organoids for Disease Modeling’, Protein & Cell, 8(5), pp. 315–327. Available at: https://doi.org/10.1007/s13238-016-0368-0.

Takarabio Tet Systems Resources (no date). Available at: https://www.takarabio.com/learning-centers/gene-function/inducible-systems/tet-inducible-systems/tet-systems-overview.

Talbot, K. and Tizzano, E.F. (2017) ‘The Clinical Landscape for SMA in a New Therapeutic Era’, Gene Therapy, 24(9), pp. 529–533. Available at: https://doi.org/10.1038/gt.2017.52.

Tsien, R.Y. (1998) ‘The Green Fluorescent Protein’, Annual Review of Biochemistry, 67(1), pp. 509–544. Available at: https://doi.org/10.1146/annurev.biochem.67.1.509.

Vance, M.A., Mitchell, A. and Samulski, R.J. (2015) ‘AAV Biology, Infectivity and Therapeutic Use From Bench to Clinic’, in D. Hashad (ed.) Gene Therapy - Principles and Challenges. InTech. Available at: https://doi.org/10.5772/61988.

Veltman, D.M. et al. (2009) ‘A New Set of Small, Extrachromosomal Expression Vectors for Dictyostelium Discoideum’, Plasmid, 61(2), pp. 110–118. Available at: https://doi.org/10.1016/j.plasmid.2008.11.003.

Verma, I.M. and Weitzman, M.D. (2005) ‘Gene Therapy: Twenty-First Century Medicine’, Annual Review of Biochemistry, 74(1), pp. 711–738. Available at: https://doi.org/10.1146/annurev.biochem.74.050304.091637.

Vigna, E. and Naldini, L. (2000) ‘Lentiviral Vectors: Excellent Tools for Experimental Gene Transfer and Promising Candidates for Gene Therapy’, The Journal of Gene Medicine, 2(5), pp. 308–316. Available at: https://doi.org/10.1002/1521-2254(200009/10)2:5<308::AID-JGM131>3.0.CO;2-3.

Walker, M.C. and Williams, R.S.B. (2013) ‘The Search for Better Epilepsy Treatments: From Slime Mould to Coconuts’, Biochemical Society Transactions, 41(6), pp. 1625–1628. Available at: https://doi.org/10.1042/BST20130183.

Wanisch, K. and Yáñez-Muñoz, R.J. (2009) ‘Integration-Deficient Lentiviral Vectors: A Slow Coming of Age’, Molecular Therapy, 17(8), pp. 1316–1332. Available at: https://doi.org/10.1038/mt.2009.122.

Weijer, C.J. and Williams, J.G. (2009a) ‘Dictyostelium: Cell Sorting and Patterning’, in Encyclopedia of Life Sciences. Wiley Interscience. Available at: https://doi.org/10.1002/9780470015902.a0001116.pub2.

Weijer, C.J. and Williams, J.G. (2009b) ‘Dictyostelium: Cell Sorting and Patterning’, in Encyclopedia of Life Sciences. Wiley Interscience. Available at: https://doi.org/10.1002/9780470015902.a0001116.pub2.

Williams, J.G. (2006) ‘Transcriptional Regulation of Dictyostelium Pattern Formation’, EMBO Reports, 7(7), pp. 694–698. Available at: https://doi.org/10.1038/sj.embor.7400714.

Williams, J.G. (2010a) ‘Dictyostelium Finds New Roles to Model’, Genetics, 185(3), pp. 717–726. Available at: https://doi.org/10.1534/genetics.110.119297.

Williams, J.G. (2010b) ‘Dictyostelium Finds New Roles to Model’, Genetics, 185(3), pp. 717–726. Available at: https://doi.org/10.1534/genetics.110.119297.

Williams, R.S.B. et al. (2002) ‘A Common Mechanism of Action for Three Mood-Stabilizing Drugs’, Nature, 417(6886), pp. 292–295. Available at: https://doi.org/10.1038/417292a.

Williams, R.S.B. (2005) ‘Pharmacogenetics in Model Systems: Defining a Common Mechanism of Action for Mood Stabilisers’, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(6), pp. 1029–1037. Available at: https://doi.org/10.1016/j.pnpbp.2005.03.020.

Williams, R.S.B. and Boeckeler, K. (2006) ‘Towards a Molecular Understanding of Human Diseases Using Dictyostelium Discoideum’, Trends in Molecular Medicine, 12(9), pp. 415–424. Available at: https://doi.org/10.1016/j.molmed.2006.07.003.

Williams, R.S.B. and Eames, M. (1999) ‘Loss of a Prolyl Oligopeptidase Confers Resistance to Lithium by Elevation of Inositol (1,4,5) Trisphosphate’, The EMBO Journal, 18(10), pp. 2734–2745. Available at: https://doi.org/10.1093/emboj/18.10.2734.